Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome makes decreases

.After increasing $213 thousand in 2023-- one of the year's biggest personal biotech shots-- Tome Bi...

BioMarin develops officer crew along with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, shooting...

Biopharma Q2 VC attacked highest level given that '22, while M&ampA slowed

.Financial backing financing right into biopharma cheered $9.2 billion throughout 215 sell the secon...

Bicara, Zenas find IPOs to push late-phase resources toward market

.Bicara Rehabs and Zenas Biopharma have supplied clean incentive to the IPO market along with filing...

Genentech to finalize cancer cells immunology analysis department

.Genentech will certainly shut its cancer immunology research study department, as well as system mi...

Kezar falls solid tumor but to verify its worth in period 1 test

.Kezar Lifestyle Sciences is losing its dim period 1 sound growth drug as the biotech goes all-in on...

Acelyrin goes down izokibep, lets go 3rd of workers

.Even with izokibep sustaining its own newly found winning touch in the facility, Acelyrin is actual...

Rivus' stage 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid stops preclinical work, IV program after soticlestat fail

.Ovid Therapy currently showed final month that it was trimming back its own headcount as the firm b...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Port, improving its RN...